The influence of propofol and remifentanil combined anesthesia on electroencephalogram spectrum

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-13003141

Enrollment

Unknown

Registered

2013-04-05

Start date

2013-04-30

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The influence of propofol, remifentanil on electroencephalogram

Interventions

P:propofol anesthesia

PR:propofol, remifentanil combined anesthesia

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 18 to 75; 2. ASA I-III; 3. People accepted the informed consent file.

Exclusion criteria

Exclusion criteria: 1. participated in other clinical trials four weeks ago the start of this study; 2. Taking neurological drugs 2 weeks ago the beginning of the experiment; 3. Respiratory depression, (lung) airway obstruction or hypoxia; 4. Cardiac disorders (level II and above level II cardiac function; 5. Liver, kidney dysplasia (indicators higher than the normal twice); 6. Nervous system disease; 7. allergy to Propofol and/or remifetanil; 8. Drugs and/or alcohol abuse; 9. Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
electroencephalography;	—

Secondary

Measure	Time frame
OAA/S;	—

Countries

China

Contacts

Public ContactQi Wu

wuqimed@126.com+86 18660150557

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026